Literature DB >> 31919883

Terminal osseous dysplasia with pigmentary defects in a Chinese girl with the FLNA mutation: A case report and published work review.

Zhongtao Li1, Yao Xie1, Qiankun Xiao2, Lin Wang1.   

Abstract

Terminal osseous dysplasia with pigmentary defects (TODPD) is an extremely rare X-linked dominant syndrome characterized by pigmentary skin defects, cutaneous digital fibromas and skeletal anomalies. Recent studies have identified that TODPD is caused by a unique variant, c.5217G>A (p.Val1724_Thr1739del), in the FLNA gene, which could in turn lead to the elastic fiber abnormality in TODPD. We herein present a rare case of TODPD in a Chinese girl due to an FLNA c.5217G>A heterozygous mutation, but the skin lesion biopsy showed that the elastic fibers were within normal limits in the dermis. A published work review of TODPD with the FLNA mutation from various origins is also included in this paper. To the best of our knowledge, this is the first report on TODPD with the FLNA mutation in China.
© 2020 Japanese Dermatological Association.

Entities:  

Keywords:  Chinese; FLNA mutation; digital fibroma; elastic fiber; terminal osseous dysplasia with pigmentary defects

Mesh:

Substances:

Year:  2020        PMID: 31919883     DOI: 10.1111/1346-8138.15209

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro.

Authors:  Joann Diray-Arce; Asimenia Angelidou; Kristoffer Jarlov Jensen; Maria Giulia Conti; Rachel S Kelly; Matthew A Pettengill; Mark Liu; Simon D van Haren; Scott D McCulloch; Greg Michelloti; Olubukola Idoko; Tobias R Kollmann; Beate Kampmann; Hanno Steen; Al Ozonoff; Jessica Lasky-Su; Christine S Benn; Ofer Levy
Journal:  Cell Rep       Date:  2022-05-03       Impact factor: 9.995

2.  A de novo heterozygous variant in the SON gene is associated with Zhu-Tokita-Takenouchi-Kim syndrome.

Authors:  Lianlian Yang; Fan Yang
Journal:  Mol Genet Genomic Med       Date:  2020-09-14       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.